Goldsite's Debut at MEDICA 2023

Grand Opening Highlights

World's Attention Focused on MEDICA 2023

Düsseldorf, Germany- Today marks the grand opening of the 2023 MEDICA exhibition in Düsseldorf, Germany, drawing the global medical industry's attention. After months of meticulous preparation, the Goldsite team debuts with several innovative products, demonstrating its significant industry influence at this world-class medical laboratory event. As a top-tier global medical event, this year's MEDICA has attracted 4,600 exhibitors from 66 countries and 81,000 visitors, witnessing a historic moment in the industry.

At the Forefront of Medical Technology and Knowledge Exchange

The MEDICA in Düsseldorf, Germany, recognized as the world's largest hospital and medical equipment exhibition, has always been a stage for showcasing the latest in medical technology and knowledge innovation, providing an unparalleled platform for information exchange among medical professionals.

Since its establishment in 1999, Goldsite has formed a deep bond with Germany, participating annually in MEDICA. This year, Goldsite's booth, spanning 36 square meters and located at the prime position of 1/B56 in Hall 1, signifies MEDICA's high regard for Goldsite's brand value and its status in the field of in vitro diagnostics (IVD).

Expanding Horizons: Goldsite's International Presence

Reflecting on the past three years, Goldsite's efforts in exploring international markets have never ceased. After the global pandemic, the Goldsite international team returned to Düsseldorf with renewed aspirations. Notably, this year marks the introduction of our Omlipo specific protein instrument and the HbA1c analyzer into the Czech market. While our GPP-100 had successfully entered Sweden in 2019, Goldsite's influence continues to extend across Europe, the Middle East, and Africa, highlighted by significant achievements such as the GSH-60 installations in various countries.

Showcasing Innovation at MEDICA 2023

At this year's MEDICA, Goldsite is showcasing several flagship products, for instance, the GPP-100 specific protein platform, which was first launched in 2019, it has already established a strong brand reputation with breakthroughs in multiple European markets. In the realm of HbA1c testing, Goldsite introduces two innovative instruments: the GSH-60 high-performance liquid chromatography (HPLC) analyzer and the A1c Go POCT HbA1c Analyzer, each designed for distinct testing environments. Additionally, our newly introduced FIA Go fluorescence POCT analyzer and the latest 3-Part Differentiation GH-3100 hematology analyzer are making their first appearance at MEDICA

.

With the first day of the exhibition concluded successfully, the event will continue for three more days, until November 16th. Goldsite team extends a warm invitation to both familiar and new faces to visit us at booth 1/B56 for engaging discussions and interactions. We are keenly anticipating feedback from industry professionals on our products and are excited about the opportunity to explore further advancements in the IVD field together.